Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 192

Similar articles for PubMed (Select 19660809)

1.

A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.

Xiao K, Luo J, Fowler WL, Li Y, Lee JS, Xing L, Cheng RH, Wang L, Lam KS.

Biomaterials. 2009 Oct;30(30):6006-16. doi: 10.1016/j.biomaterials.2009.07.015. Epub 2009 Aug 5.

2.

"OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.

Xiao K, Li Y, Lee JS, Gonik AM, Dong T, Fung G, Sanchez E, Xing L, Cheng HR, Luo J, Lam KS.

Cancer Res. 2012 Apr 15;72(8):2100-10. doi: 10.1158/0008-5472.CAN-11-3883. Epub 2012 Mar 6.

3.

A novel size-tunable nanocarrier system for targeted anticancer drug delivery.

Li Y, Xiao K, Luo J, Lee J, Pan S, Lam KS.

J Control Release. 2010 Jun 15;144(3):314-23. doi: 10.1016/j.jconrel.2010.02.027. Epub 2010 Mar 6.

4.

PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.

Lu J, Huang Y, Zhao W, Marquez RT, Meng X, Li J, Gao X, Venkataramanan R, Wang Z, Li S.

Biomaterials. 2013 Feb;34(5):1591-600. doi: 10.1016/j.biomaterials.2012.10.073. Epub 2012 Nov 23.

5.

Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.

Danhier F, Magotteaux N, Ucakar B, Lecouturier N, Brewster M, Préat V.

Eur J Pharm Biopharm. 2009 Oct;73(2):230-8. doi: 10.1016/j.ejpb.2009.06.015. Epub 2009 Jul 3.

PMID:
19577643
6.

Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.

Li Y, Xiao K, Luo J, Xiao W, Lee JS, Gonik AM, Kato J, Dong TA, Lam KS.

Biomaterials. 2011 Sep;32(27):6633-45. doi: 10.1016/j.biomaterials.2011.05.050. Epub 2011 Jun 11.

7.

Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.

Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q.

Int J Pharm. 2014 Aug 25;471(1-2):525-35. doi: 10.1016/j.ijpharm.2014.05.032. Epub 2014 May 22.

PMID:
24858391
8.

Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.

Soga O, van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, Hennink WE.

J Control Release. 2005 Mar 21;103(2):341-53.

PMID:
15763618
9.

Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.

Koo H, Min KH, Lee SC, Park JH, Park K, Jeong SY, Choi K, Kwon IC, Kim K.

J Control Release. 2013 Dec 28;172(3):823-31. doi: 10.1016/j.jconrel.2013.08.297. Epub 2013 Sep 11.

PMID:
24035978
10.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.

PMID:
20056123
11.

Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.

Zhao T, Chen H, Dong Y, Zhang J, Huang H, Zhu J, Zhang W.

Int J Nanomedicine. 2013;8:1947-57. doi: 10.2147/IJN.S44220. Epub 2013 May 16.

12.

A PEG-Fmoc conjugate as a nanocarrier for paclitaxel.

Zhang P, Huang Y, Liu H, Marquez RT, Lu J, Zhao W, Zhang X, Gao X, Li J, Venkataramanan R, Xu L, Li S.

Biomaterials. 2014 Aug;35(25):7146-56. doi: 10.1016/j.biomaterials.2014.04.108. Epub 2014 May 22.

PMID:
24856103
13.

Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.

Bernabeu E, Helguera G, Legaspi MJ, Gonzalez L, Hocht C, Taira C, Chiappetta DA.

Colloids Surf B Biointerfaces. 2014 Jan 1;113:43-50. doi: 10.1016/j.colsurfb.2013.07.036. Epub 2013 Sep 5.

PMID:
24060929
14.

Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.

Zhang R, Luo K, Yang J, Sima M, Sun Y, Janát-Amsbury MM, Kopeček J.

J Control Release. 2013 Feb 28;166(1):66-74. doi: 10.1016/j.jconrel.2012.12.009. Epub 2012 Dec 20.

15.

Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.

Javid A, Ahmadian S, Saboury AA, Kalantar SM, Rezaei-Zarchi S, Shahzad S.

Appl Biochem Biotechnol. 2014 May;173(1):36-54. doi: 10.1007/s12010-014-0740-6. Epub 2014 Mar 11.

PMID:
24615524
16.

Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.

Yu DH, Lu Q, Xie J, Fang C, Chen HZ.

Biomaterials. 2010 Mar;31(8):2278-92. doi: 10.1016/j.biomaterials.2009.11.047. Epub 2010 Jan 6.

PMID:
20053444
17.

Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.

Feng Z, Zhao G, Yu L, Gough D, Howell SB.

Cancer Chemother Pharmacol. 2010 Apr;65(5):923-30. doi: 10.1007/s00280-009-1099-1. Epub 2009 Aug 15.

18.

PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.

Zhang X, Lu J, Huang Y, Zhao W, Chen Y, Li J, Gao X, Venkataramanan R, Sun M, Stolz DB, Zhang L, Li S.

Bioconjug Chem. 2013 Mar 20;24(3):464-72. doi: 10.1021/bc300608h. Epub 2013 Mar 1.

19.

Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.

Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H.

Biomaterials. 2008 Mar;29(9):1233-41.

PMID:
18093646
20.

Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel.

Wang C, Wang Y, Wang Y, Fan M, Luo F, Qian Z.

Int J Pharm. 2011 Jul 29;414(1-2):251-9. doi: 10.1016/j.ijpharm.2011.05.014. Epub 2011 May 10.

PMID:
21596124
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk